AGTR1 and breast cancer: In a murine breast cancer (4T1‐luc) experimental lung metastasis model, treatment with losartan (60 mg/kg) mediated AT1R‐independent anti‐metastatic effects, likely through inhibiting CCR2‐dependent monocyte recruitment [119].